Trial intelligence / Profile preview

Fresh gas flow and speed of sevoflurane inhalational induction in children

IRCT20220301054154N1Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of sevoflurane (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Time to Bispectral Index 60 to 70, Time to loss of response to trapezius squeeze and 5 more. Started Oct 2021; status: completed.

02

Drugs

sevoflurane

Beyond the preview

Go deeper on IRCT20220301054154N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220301054154N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call